Salinocaine Ointment
NDC Package 10733-415-40
Package Information
Salinocaine (salicylic acid and benzocaine) ointment is each Gram Contains: 550mg of Salicylic acid and 20mg of Benzocaine. This formulation utilizes a ointment delivery system. Marketed by Medical Products Laboratories, Inc., this product is identified by NDC 10733-415.
Identification & Billing
- RxCUI: 1603377 - salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment
- RxCUI: 1603377 - benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment
- RxCUI: 1603377 - benzocaine 2 % / salicylic acid 55 % Topical Ointment
- RxCUI: 1603382 - Salinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment
- RxCUI: 1603382 - benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10733 - Medical Products Laboratories, Inc.
- 10733-415 - Salinocaine
- 10733-415-40 - 40 g in 1 JAR
- 10733-415 - Salinocaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10733-415-40 identifies a specific commercial package of 40 g in 1 jar of Salinocaine, a human prescription drug labeled by Medical Products Laboratories, Inc.. This ointment is formulated for topical use and contains benzocaine; salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Products Laboratories, Inc. on June 01, 1938. The current certification is valid through December 31, 2026.
How is this Medical Products Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10733041540. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.